Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients - Concepedia

Concepedia

Publication | Closed Access

Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients

588

Citations

20

References

2008

Year

Felix Zeppernick, Rezvan Ahmadi, Benito Campos, Christine Dictus, Burkhard Helmke, Natália Becker, Peter Lichter, Andreas Unterberg, Bernhard Radlwimmer, Christel Herold‐Mende

Clinical Cancer Research

Abstract

These findings constitute the first conclusive evidence that CD133 stem cell antigen expression correlates with patient survival in gliomas, lending support to the current cancer stem cell hypothesis.

References

	Year	Citations

Page 1